Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion type Assertion NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_head.
- NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion description "[Applying this dataset to triple-negative breast cancer, we report clinically actionable interactions with the MYC oncogene, including resistance to AKT-PI3K pathway inhibitors and an unexpected sensitivity to dasatinib through LYN inhibition in a synthetic lethal manner, providing new drug and biomarker pairs for clinical investigation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_provenance.
- NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion evidence source_evidence_literature NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_provenance.
- NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion SIO_000772 25501949 NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_provenance.
- NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion wasDerivedFrom befree-2016 NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_provenance.
- NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_assertion wasGeneratedBy ECO_0000203 NP1247664.RA0am6eCwLDGaRsDF8UqPoMlDqD_ct6LZb2jIrWeMEJbo130_provenance.